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Abstract 8 
Polynesian individuals are leaner with greater musculature than Caucasians of an 9 
equivalent size, and this genetically different morphology provides a physique that is 10 
often compatible with success in a number of sports, including rugby union. Evidence 11 
indicates that Polynesians have greater stores of absolute and relative abdominal fat 12 
mass and this is known to confer cardiometabolic risk. The aims of this study were to 13 
1) explore the relationship between ethnicity, visceral adipose tissue (VAT), and 14 
cardiometabolic disease risk markers in elite Caucasian and Polynesian rugby union 15 
athletes, and 2) assess the impact of a pre-season training program on these markers. 16 
Twenty-two professional rugby union athletes of Caucasian (n=11) and Polynesian 17 
(n=11) descent underwent physique assessment via surface anthropometry, dual-18 
energy X-ray absorptiometry, and magnetic resonance imaging before and after an 11-19 
week pre-season. A fasted blood test was undertaken at both time points. Compared to 20 
Caucasians, at baseline Polynesians displayed significantly higher VAT (771 ± 609 21 
cm3 vs 424 ± 235 cm3; p=0.043), triglycerides (1.0 ± 0.9 mmol/L vs 0.6 ± 0.2 22 
mmol/L; p=0.050), and low-density lipoprotein cholesterol (3.1 ± 0.9 mmol/L vs 2.3 23 
± 0.7 mmol/L; p=0.019). Similar changes were observed in both groups over the pre-24 
season period in VAT and blood biochemical markers. Polynesian rugby union 25 
 2 
athletes were more likely than Caucasians to exhibit risk factors associated with 26 
cardiometabolic disease, such as elevated VAT and unfavourable lipid profiles. 27 
Further longitudinal research is required to identify and explain the short- and long-28 
term risk of cardiometabolic disease in athletes of Polynesian descent. 29 
 30 
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 32 
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Introduction 35 
 36 
Rugby union is a contact team sport which places significant physiological demands 37 
on the athlete (Bradley et al., 2015). The development of lean mass is desirable to 38 
enhance speed, strength and power, which are fundamental attributes for competitive 39 
success (Olds, 2001). Additionally, body mass has been identified as being strongly 40 
associated with overall team performance (Olds 2001, Sedeaud et al., 2012). The 41 
emphasis on muscularity and overall size may explain the anecdotal rise in Polynesian 42 
athletes competing at the elite level in rugby union. Additionally, it may rationalise 43 
the relative success of national teams from Pacific nations in international 44 
competition, with Fiji, a country with a population of 900,000 having a comparable 45 
world ranking to that of France with a population of 67 million (as of May 2019). 46 
Polynesians have been shown to be significantly leaner with greater muscle mass than 47 
Caucasians at an equivalent body mass index (BMI) (Swinburn, Ley, Carmichael, & 48 
Plank, 1999). Furthermore, they display proportionally higher levels of fat free mass 49 
and lower levels of fat mass after adjustments for stature and mass (Rush, Freitas, & 50 
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Plank, 2009). As such, the genetic morphology of Polynesians appears to predispose 51 
them to a physique compatible with success in rugby union. 52 
 53 
A large proportion of elite rugby union athletes are defined as overweight or obese 54 
using the traditional Caucasian ethnicity BMI cut-offs of 25–30 kg/m2 and >30 kg/m2, 55 
respectively (Zemski, Keating, Broad, Marsh, & Slater, 2018), but BMI is not suitable 56 
for estimating fat mass in athletic populations (Ackland et al., 2012). Waist 57 
circumference (WC) (Alberti, Zimmet, & Shaw, 2006) and waist to height ratio 58 
(WHt) (Swainson, Batterham, Tsakirides, Rutherford, & Hind, 2017) are commonly 59 
used to identify increased disease risk associated with higher abdominal adiposity, 60 
with a recent study identifying WHt to be a superior measure for obesity 61 
characterisation in adults (Swainson et al., 2017). However, the application of these 62 
measures to an athletic population with unique morphology, such as that found in 63 
rugby union, is questionable due to the different ratio of fat and lean mass in athletic 64 
individuals compared to the general population (Ackland et al., 2012). It is now 65 
recognised that the topography of body fat is a better predictor of cardiometabolic 66 
complications than the overall amount of fat mass (Tchernof & Despres, 2013). 67 
Indeed, high levels of visceral adipose tissue (VAT), which encompasses fat stores in 68 
the intra-abdominopelvic region bounded by the abdominal wall and pelvic floor 69 
(Shen et al., 2003), is an established marker for cardiometabolic risk and is 70 
independent of total body mass, total body fat and subcutaneous adipose tissue (SAT) 71 
(Despres & Lemieux, 2006). Additionally, VAT has been identified as an important 72 
risk factor for atherosclerosis in men (Lear et al., 2007) and there is evidence 73 
identifying a relationship between VAT and cardiovascular endpoints (Hughes-74 
Austin, Larsen, & Allison, 2013). This is of particular pertinence to Polynesians, who 75 
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possess greater stores of abdominal fat mass than Caucasians in both absolute and 76 
relative terms (Rush et al., 2009). Despite Polynesians having some of the highest 77 
rates of obesity and cardiometabolic disease worldwide (Ng et al., 2013), VAT has 78 
not been reported in general Polynesian populations. 79 
 80 
Studies in overweight and obese populations have revealed that exercise lowers risk 81 
of cardiometabolic disease risk (Barry et al., 2014), reduces VAT (Ismail, Keating, 82 
Baker, & Johnson, 2012), and lessens the adverse effects of obesity on morbidity and 83 
mortality (Fogelholm, 2010). Nonetheless, “supersized” athletes – those who 84 
purposefully maximise their lean and/or fat mass to optimise performance is a 85 
particular sport and/or position –  have been shown to display signs of elevated 86 
cardiometabolic disease risk, including compromised lipid profiles (Guo, Zhang, 87 
Wang, Guo, & Xie, 2013; Tucker et al., 2009) and higher VAT levels (Bosch et al., 88 
2014; Murata, Oshima, Torii, Taguchi, & Higuchi, 2016) compared to non-89 
heavyweight athletes or non-athletic controls. It is possible that elevated lipid markers 90 
in the presence of regular training may be an indicator of cardiovascular disease risk. 91 
Indeed, American football (NFL) linemen, the largest athletes in the sport, have 92 
almost double the prevalence of metabolic syndrome post-retirement compared to 93 
non-linemen (59.8 % vs 30.1 %; p < 0.001) (Miller et al., 2008). Recently, elite rugby 94 
union athletes of Polynesian decent were shown not to have significantly different 95 
VAT compared to Caucasians (Zemski et al., 2018). However, this observation was 96 
based on single slice MRI and there is no general agreement as to the best location to 97 
take this measurement (Schweitzer et al., 2015). Further, studies sampling single slice 98 
VAT have been observed to be influenced by ethnicity (Demerath et al., 2007). No 99 
study has investigated levels of VAT using a volumetric measure in elite athletic 100 
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populations, nor have ethnic differences in biochemical markers of cardiometabolic 101 
disease risk been examined in an elite rugby union population.  102 
 103 
Given the increased number of Polynesians in professional rugby union, and the 104 
increasing size of elite athletes within the sport, an understanding of cardiometabolic 105 
disease risk in this population would be valuable to practitioners to assist with athlete 106 
management from a health care perspective. Therefore, the aims of this study were to: 107 
1) explore the relationship between ethnicity, VAT, and cardiometabolic disease risk 108 
markers in elite rugby union athletes of Caucasian and Polynesian descent; and 2) 109 
assess the impact of a pre-season training program on levels of VAT and biochemical 110 
markers of cardiometabolic disease risk. 111 
 112 
Materials and Methods 113 
 114 
Participants 115 
 116 
Twenty-two male professional rugby union athletes were recruited via their 117 
involvement in a Super Rugby franchise. Informed consent was obtained from all 118 
athletes included in the study, and protocols were submitted to, and approved by, the 119 
relevant institutional review boards and ethics committees for testing of human 120 
subjects. 121 
  122 
At the time of consent the athletes provided the ethnicity of their grandparents via 123 
open ended questions. As this study investigated the role of phenotype expression, 124 
grandparental heritage was chosen as in previous research (Zemski et al., 2018). The 125 
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athletes were ascribed a specific ethnicity if three or four of their grandparents were of 126 
the same ethnicity. 127 
 128 
Study design 129 
 130 
As part of the physical preparation for the Super Rugby season, the athletes undertook 131 
a high-volume, high-intensity, 11-week pre-season program (November – February) 132 
with the aims of increasing strength and power and improving aerobic and anaerobic 133 
fitness; some of which can be favourably impacted by strategic body composition 134 
manipulation (Bilsborough, Greenway, Livingstone, Cordy, & Coutts, 2016). During 135 
the first three days of pre-season, the athletes undertook routine physique assessment 136 
via surface anthropometry and dual-energy X-ray absorptiometry (DXA). In addition, 137 
they received a magnetic resonance imaging (MRI) scan of their abdominal cavity. 138 
Athletes were re-assessed using the same techniques within the final three days of the 139 
pre-season period. A fasted blood test was undertaken at the same time points.  140 
 141 
Surface anthropometry 142 
 143 
An International Society for the Advancement of Kinanthropometry (ISAK) Level 3 144 
accredited anthropometrist with a historical technical error of measurement (TEM) of 145 
1.7% for sum of seven skinfolds performed all measurements. Body mass was 146 
assessed using electronic scales (A&D Mercury, Adelaide, Australia) to 0.1 kg 147 
accuracy, and stature measured using a mobile stadiometer (Seca 213, Birmingham, 148 
UK) to 0.1 cm accuracy. Both measurements were made on arrival at the testing 149 
facility after an overnight fast and with bladder voided. Athletes were provided with 150 
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guidelines on what foods and fluids to consume the day before testing, including the 151 
time at which they were to consume their last meal. This was replicated at both testing 152 
time points. Skinfolds were assessed using Harpenden calipers (British Indicators, 153 
Hertfordshire, UK) to 0.1 mm precision. All anthropometric equipment was calibrated 154 
as recommended by the manufacturers. 155 
 156 
Skinfold and waist circumference measurements were made using ISAK      157 
techniques (Norton et al., 2006). Skinfolds were assessed across seven sites: triceps, 158 
subscapular, biceps, supraspinale, abdominal, mid-thigh, and medial calf. For athletes 159 
for whom a reliable skinfold could not be taken at the abdominal site 5 cm from the 160 
umbilicus, the site was moved to 10 cm from the umbilicus at both time points. Waist 161 
circumference was measured at the level of the narrowest point between the lower 162 
costal border and the iliac crest and taken at the end of normal expiration. All 163 
measurements were undertaken in duplicate to establish within-day retest reliability. 164 
If the difference between the duplicate measures exceeded 4% for an individual 165 
skinfold or 1% for waist circumference, a third measurement was taken. The mean of 166 
duplicate or the median of triplicate anthropometric measurements were used for all 167 
subsequent analysis. BMI was calculated using the formula mass (kg) divided by 168 
stature (m) squared. WHt ratio was calculated using the formula waist circumference 169 
(cm) divided by stature (cm). 170 
 171 
Dual-energy X-ray absorptiometry 172 
 173 
All athletes received whole body composition analysis via scans on a fan-beam DXA 174 
system (Hologic Discovery A, Hologic, Bedford, MA), with Apex 13.4.2:3 software 175 
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(Hologic, Bedford, MA). The scanner was calibrated daily using a phantom as per 176 
manufacturer guidelines for quality control purposes.  177 
 178 
Scanning protocols were implemented using proven techniques to maximise technical 179 
reliability and minimise error (Nana, Slater, Stewart, & Burke, 2015). Specifically, 180 
the athletes were scanned prior to food and fluid ingestion, or exercise, early in the 181 
morning (5:00 – 8:30 am). Athletes were provided with guidelines on what foods and 182 
fluids to consume the day before testing, including the time at which they were to 183 
consume their last meal. This was replicated at both testing time points. The athletes 184 
were scanned wearing sports shorts and those taller than the defined 196 cm scanning 185 
boundary were subject to two scans. The first scan was used to capture the body from 186 
the menton (the inferior point of the mandible) down whilst the head was positioned 187 
in the Frankfort plane. After body repositioning on the scanner and realignment of the 188 
head into the Frankfort plane, a second scan was taken to capture from the menton up 189 
to the vertex of the head. The results were then combined post-analysis to produce 190 
whole body composition scans. For positioning consistency the same experienced and 191 
qualified technician performed all measurements using the Nana et al. positioning 192 
protocol previously described (Nana et al., 2015). The same qualified technician 193 
undertook all post-scan analysis, including the manual adjustment of all regions of 194 
interest. Auto positioning of the VAT area was used, with manual adjustments made 195 
to the edge of subcutaneous fat placement and visceral cavity area if required. 196 
 197 
Magnetic resonance imaging 198 
 199 
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Abdominal SAT and VAT were measured on a PRISMA 3T MRI (Siemens 200 
Healthineers, Erlangen, Germany) at the Herston Imaging Research Facility 201 
(Brisbane, Queensland, Australia) by a qualified and experienced technician. A 32-202 
channel spine array coupled with a 30-channel body array was utilised to perform the 203 
examination. Coverage extended from the diaphragm to the L5/S1 junction. The 204 
athletes were positioned either head first or feet first depending on their body habitus, 205 
and this position was repeated at the follow-up scan. Axial T1 weighted Dixon images 206 
were acquired in a single breath hold (TR 3.97 ms, TE 1.23/2.46 ms, flip angle 9°, 207 
matrix 320X240) with slice thickness of 4mm and no inter-slice gaps. The field of 208 
view (FOV) was 450 mm in order to include the skin surface.  209 
 210 
Cross-sectional areas and volumes of both abdominal SAT and VAT from L5/S1 to 211 
the diaphragm were measured by semi-automated specialized software (Slice-O-matic 212 
version 5.0; Tomovision, Montréal, Canada). SAT was quantified using the 213 
“mathematical morphology” function and VAT using the “region growing” function, 214 
with thresholds adjusted manually for each slice. All images were analysed by a 215 
single trained observer who was not informed of athlete ethnicity and playing 216 
position. Examples of the output provided by image analysis process is shown in 217 
Appendix 1. Presently, there are no established reference ranges indicating increased 218 
risk or cardiometabolic complications for VAT volume given it is a relatively new 219 
assessment. Intra-observer variability was assessed by re-analysing 11 randomly 220 
selected scans after a minimum 3-month interval.  221 
 222 
Blood biochemistry 223 
 224 
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Venous blood (20ml) was collected from the antecubital vein after an overnight fast 225 
(>10 hours). On the same day serum glucose, insulin, total cholesterol (TC), 226 
triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density 227 
lipoprotein cholesterol (LDL-C) concentrations were analysed by a commercially 228 
accredited laboratory (QML Pathology, Specialist Diagnostic Services Pty Ltd, NSW, 229 
Australia). Analysis was conducted using a Siemens ADVIA 1800 Chemistry System 230 
(Siemens Healthineers, Erlangen, Germany) with the associated Siemens testing kit 231 
and recommended reagents. Blood was centrifuged for 10 minutes at 3000 g. This 232 
allowed the red blood cells to be collected at the bottom of the tube below the gel, 233 
and the serum to be collected at the top of the tube. The serum was analysed to test 234 
fasting glucose and insulin, and a full lipid profile, which included TG, TC, HDL-C and 235 
LDL-C. 236 
 237 
Training 238 
 239 
Athletes undertook an 11-week pre-season program. This followed a period of 4-240 
weeks of leave, which included an active rest schedule of two strength and two 241 
conditioning sessions a week. The pre-season comprised a 4-week supervised training 242 
block prior to a 2-week unsupervised maintenance block, followed by another 5-week 243 
supervised training block. Throughout each training week, technical (x2/week) and 244 
tactical (x4/week) rugby sessions along with sessions to improve physical qualities 245 
and body composition were performed (speed/agility x1/week, strength x4/week, 246 
conditioning x3-4/week, boxing x1/week). Weekly training time was approximately 247 
15 hours, with additional time spent on recovery and regeneration modalities 248 
(flexibility, mobility, massage, hydrotherapy and physiotherapy). All athletes were 249 
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injury and illness free at the start of the pre-season period, and did not suffer from any 250 
significant injuries or illnesses that meaningfully restricted their training during the 251 
study period. All athletes were under the management of an experienced sports 252 
dietitian and received individualised dietary plans and group education sessions aimed 253 
at supporting training adaptations throughout the pre-season period. 254 
 255 
Statistical analysis 256 
 257 
Statistical analysis procedures were completed using SPSS (Version 22.0, IBM Corp., 258 
Armonk, NY) and Microsoft Excel 2011 (Microsoft, Redmond, WA, USA). Before 259 
analysis, assumptions of normality in the data were made using the Shapiro-Wilk test 260 
and visualisations of normality histograms and Q-Q plots. If data were not normally 261 
distributed they were log transformed using the natural logarithm for all subsequent 262 
analyses. Independent t-tests were used to test for differences in body composition 263 
traits and cardiometabolic risk markers according to ethnicity at baseline. A one-way 264 
analysis of covariance (ANCOVA) was conducted to determine how changes in body 265 
composition over the pre-season period varied by ethnicity, with baseline measures 266 
entered as a covariate. Bonferroni post hoc corrections were applied. Correlations 267 
were calculated using Pearson’s and Spearman’s correlations for normally distributed 268 
and nonparametric data respectively, to assess the relationship between body 269 
composition and cardiometabolic risk variables at baseline, and for changes over the 270 
pre-season period. For correlations, coefficients were qualitatively ranked by 271 
magnitude, with the strength of correlation coefficients defined as trivial, r <0.1; 272 
small, 0.1≤ r <0.3; moderate, 0.3≤ r <0.5; large, 0.5≤ r <0.7; very large, 0.7≤ r <0.9; 273 
almost perfect, 0.9≤ r <1.0; and perfect, r = 1.0. Data are presented as mean ± 274 
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standard deviation (SD), or median (inter-quartile range; IQR) for non-parametric 275 
variables, with statistical significance for all analyses defined as p ≤ 0.05. Intraclass 276 
correlation coefficients (ICC) were used to determine the test-retest reliability, whilst 277 
the coefficient of variation (CV) was calculated (standard deviation divided by the 278 
mean) to show the extent of absolute variability. 279 
 280 
Individual changes in DXA measures were evaluated through the application of least 281 
significant change (LSC) derived from precision data from a group of resistance 282 
trained athletes on the Hologic Discovery A scanner (Zemski et al., 2019). Precision 283 
error was calculated as root-mean-square standard deviation (RMS–SD), with LSC 284 
subsequently derived as RMS–SD x 2.77 (95% confidence interval; 95%–CI) (Baim 285 
et al., 2008). LSC values were also created using the same methods for surface 286 
anthropometry measures and MRI analysis using data collected within this 287 
population. 288 
 289 
 290 
Results 291 
 292 
All twenty-two athletes (age 23 ± 3 years; stature 186.8 ± 8.4 cm; mass 101.5 ± 13.7; 293 
BMI 29.0 ± 2.5 kg/m2) were able to be ascribed an ethnicity, with 11 identifying as 294 
Caucasian, and 11 as Polynesian. The ICC (95% confidence interval) for VAT was 295 
1.00 (CI 0.99–1.00) and for SAT was 1.00 (CI 0.98–1.00) with a CV of 2.0% and 296 
2.7%, respectively. The LSC- 95% CI value for the sum of 7 skinfolds was 0.7 mm 297 
(1.9% CV), 0.6 cm (0.5% CV) for waist circumference, 129.2 cm3 (4.8% CV) for 298 
SAT volume, and 28.3 cm3 (5.1% CV) for VAT volume. 299 
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 300 
Descriptive characteristics based on ethnicity are presented in Table 1. Differences 301 
were found between ethnicities at baseline, with Polynesians having significantly 302 
higher VAT (771 ± 609 cm3 vs 424 ± 235 cm3; p = 0.043), android fat mass 303 
percentage (19.4 ± 5.0 % vs 14.5 ± 3.8 %; p = 0.020), TG (1.0 ± 0.9 mmol/L vs 0.6 ± 304 
0.2 mmol/L; p = 0.050), LDL-C (3.1 ± 0.9 mmol/L vs 2.3 ± 0.7 mmol/L; p = 0.019) 305 
and WHt (0.50 ± 0.03 vs 0.47 ± 0.02; p = 0.019), whilst trending towards higher SAT 306 
(3424 ± 1529 cm3 vs 2279 ± 1014 cm3; p = 0.068) and TC (5.1 ± 0.9 mmol/L vs 4.4 ± 307 
0.8 mmol/L; p = 0.057).  308 
 309 
Significant correlations were recorded at the start of pre-season with both SAT and 310 
VAT in relation to other measures of adiposity including skinfolds, WC, and absolute 311 
and relative android and gynoid fat (Table 2). Large correlations were noted between 312 
VAT (r = 0.564, p < 0.01) and SAT (r = 0.435, p < 0.05) with TC, and very large 313 
correlations between VAT (r = 0.709, p < 0.01) and SAT (r = 0.705, p < 0.01) with 314 
TG. 315 
 316 
Ethnicity was found to be significantly related to changes over the pre-season period, 317 
with Polynesians having greater reductions in WC (-2.8 ± 1.6 cm vs -0.7 ± 1.2 cm; F 318 
= 9.208, p = 0.007) and WHt (-0.02 ± 0.009 vs -0.004 ± 0.006; F = 7.206, p = 0.015), 319 
whilst Caucasians had greater reductions in TC (-0.13 ± 0.32 mmol/L vs -0.08 ± 0.68 320 
mmol/L; F = 5.543, p = 0.029) (Table 1). 321 
 322 
Applying the LSC model, individual changes are shown in Table 3. Twenty-one 323 
(95%) athletes had reductions in VAT (exceeding LSC-95% CI) and skinfolds over 324 
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the pre-season period, whilst 19 (86%) decreased SAT and android fat mass percent 325 
(Figure 1). A similar proportion of Caucasians and Polynesians athletes made 326 
meaningful changes in all measures assessed, with the exception of WC in which a 327 
larger proportion of Polynesians (91%) made a significant decrease in comparison to 328 
Caucasians (45%). 329 
 330 
Large correlations in changes over the pre-season were found between VAT and 331 
skinfolds (r = 0.575, p < 0.01), WC (r = 0.578, p < 0.01), total fat mass (r = 0.496, p < 332 
0.05), android fat mass (r = 0.462, p < 0.05), and gynoid fat mass (r = 0.491, p < 333 
0.05). Similar or slightly larger and stronger correlations were seen between SAT and 334 
skinfolds (r = 0.689, p < 0.01), WC (r = 0.558, p < 0.01), total fat mass (r = 0.557, p < 335 
0.01), android fat mass (r = 0.625, p < 0.01), and gynoid fat mass (r = 0.488, p < 336 
0.05). 337 
 338 
Discussion 339 
 340 
In this research we were the first to assess volumetric measures of VAT in an elite 341 
athlete population and to adopt an individualised approach to the analysis of pre-342 
season adiposity changes in elite rugby union athletes. The main findings were that: 343 
(1) athletes of Polynesian descent had significantly different abdominal adiposity 344 
distribution and lipid profiles compared to Caucasian athletes; and (2) the majority of 345 
athletes achieved meaningful and favourable reductions in both abdominal VAT 346 
(95%) and SAT (86%) over the pre-season period. 347 
 348 
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Prior to this study, there was limited research on visceral adiposity in athletic 349 
populations. Bosch et al. (2014) determined that NFL linemen (mass 137.1 ± 11.7 kg; 350 
BMI 37.3 ± 3.5 kg/m2; percent fat 27.0 ± 6.0 %) have high levels of VAT as 351 
estimated by DXA compared to non-linemen (1.2 ± 0.6 kg vs. 0.3 ± 0.2 kg). 352 
Similarly, heavyweight judo athletes possessed relatively higher VAT measured by 353 
single slice MRI at L4/L5 compared to non-heavyweight athletes (91 ± 39 cm2 vs 33 354 
± 14 cm2) (Murata et al., 2016), which would have placed many above the 100 cm2 355 
diagnostic threshold for increased cardiometabolic disease risk (Pickhardt, Jee, 356 
O’Connor, & del Rio, 2012). It has previously been identified that 37% of athletes in 357 
an elite rugby union population were above the threshold for increased risk via single 358 
slice MRI, whist no differences were found between ethnicities (Zemski et al., 2018). 359 
However, this was using reference ranges developed in older and more obese 360 
populations and, therefore, the application to well-trained athletes was uncertain. 361 
Furthermore, single slice measures may be affected by ethnicity (Demerath et al., 362 
2007), and Polynesian individuals have greater absolute and relative body fat 363 
distribution in the abdominal region (Rush et al., 2009). In the current study, elite 364 
Polynesian rugby athletes had higher VAT, and trended towards having higher SAT 365 
than Caucasians, despite no statistically significant difference in total fat mass or 366 
relative fat mass. It is important to note that one Polynesian athlete had a considerably 367 
higher VAT measurement than the other ten (Figure 1). As this was a statistical but 368 
not clinical outlier, we retained this in the primary analysis. Removal of this athlete 369 
from the group mean analysis weakened the ethnicity difference in VAT marginally 370 
(from p = 0.043 to p = 0.070). Moreover, the VAT results for all athletes were 371 
investigated after being adjusted for stature, but this had no effect on the outcomes, 372 
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indicating the relative size of the individual did not make a difference to VAT 373 
accumulation. 374 
 375 
“Supersized” professional strength sport athletes in unlimited body weight    376 
categories (Guo et al., 2013) and NFL linemen (Tucker et al., 2009) have exhibited 377 
elevated blood lipid profiles compared to smaller stature athletes and/or non-athlete 378 
controls. Further, NFL linemen have an increased incidence of metabolic syndrome 379 
compared to non-linemen post-career (59.8 % vs 30.1 %; p < 0.001) (Miller et al., 380 
2008), and a higher BMI and/or WC has been associated with subclinical 381 
atherosclerosis and cardiometabolic risk in retired NFL athletes (Trexler et al., 2018). 382 
However, comparisons based on ethnicity in elite athlete populations have not 383 
previously been made. Although in this study the group mean all variables were 384 
considered to be within the normal ranges, likely owing to the young age and high 385 
activity levels of the cohort, Polynesians had higher TG and LDL-C, and a trend 386 
towards higher TC, relative to Caucasians. A number of Polynesian athletes had blood 387 
lipids that were outside of the low risk targets (Tonkin et al., 2005), including two for 388 
TC (> 6.0 mmol/L), one for TG (> 1.5 mmol/L), one for HDL-C (< 1.0 mmol/L), and 389 
six for LDL-C (> 3.0 mmol/L). Only one Caucasian had elevated LDL-C levels. No 390 
athletes were outside the normal range for fasted insulin or glucose measures.  391 
 392 
Published data implies that Polynesians have some of the highest rates of obesity and 393 
cardiometabolic disease risk worldwide (Ng et al., 2014). It is noteworthy that, in the 394 
athletic population we studied in which all athletes were undertaking comparable 395 
training programs, elevated lipid profiles were still recorded in Polynesians. The 396 
higher TC and LDL-C concentrations in Polynesian athletes may place them at 397 
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elevated risk of post-career cardiometabolic complications when activity levels are 398 
prone to decline, as has been shown in other sports with  “supersized" athletes (Miller 399 
et al., 2008; Trexler et al., 2018). This warrants further investigation of rugby union 400 
athletes after retirement, particularly given the greater focus on larger athletes is a 401 
relatively new phenomenon in the sport. 402 
 403 
Elevated VAT has been associated with dysfunctional glucose and lipid      404 
metabolism (Despres & Lemieux, 2006). In our study, higher levels of VAT showed 405 
significant correlations with TC and TG levels. It has been suggested that increased 406 
physical activity acts as a protective barrier against cardiometabolic disease risk in the 407 
general population (Barry et al., 2014) as well as “supersized” athletes (Murata et al., 408 
2016). Indeed, a recent meta-analysis in normal-weight and overweight/obese 409 
individuals reported high-intensity interval training (HIIT) has been shown to reduce 410 
VAT (Maillard, Pereira, & Boisseau, 2018). Specifically in athletic groups, elite sumo 411 
wrestlers have significantly lower visceral adiposity compared to obese controls, 412 
normal glucose and TG levels, and lower TC compared with non-obese controls 413 
(Matsuzawa, Shimomura, Nakamura, Keno, & Tokunaga, 1993). Furthermore, the 414 
significant reduction in VAT amongst Caucasians and Polynesians in this study at 415 
both the group and individual level, coupled with the absence of significant 416 
biochemical changes in cardiometabolic risk profiles, indicate that physical activity 417 
may be protective of adverse blood biochemical changes in elite athletes during their 418 
playing career. However, given “supersized” athletes have been reported to have a 419 
higher incidence of metabolic syndrome (Miller et al., 2008) and other obesity related 420 
complications post-career (Trexler et al., 2018), health status should continue to be 421 
monitored after retirement in conjunction with athlete follow-up and support. 422 
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 423 
The results of this study indicate that Polynesian rugby union athletes have higher 424 
levels of VAT and blood lipid markers than their Caucasian peers, with the underlying 425 
reasons for this possibly dating back to physiological traits that have evolved over 426 
millennia (Bindon & Baker., 1997). Future investigations encompassing longitudinal 427 
studies, incorporating end of season measures of VAT and blood biochemical markers 428 
to assess changes during the off-season period, would be valuable. Additionally, 429 
studies exploring cardiometabolic health and broader health issues of rugby union 430 
athletes post-retirement would be beneficial. This would add a holistic view to the 431 
research being undertaken on long-term health status of retired rugby union athletes 432 
(Hume et al., 2017).  433 
 434 
There were some limitations identified with this study. First, it was not possible to 435 
accurately quantify dietary intake over a long period (Magkos & Yannakoulia, 2003), 436 
or the training associated energy expenditure of the athletes given the high-intensity 437 
nature of the training being undertaken (Drenowatz & Eisenmann, 2011) together 438 
with the frequent physical collisions (Bradley et al., 2015). This information may 439 
have afforded additional insight into the underlying reasons for changes and 440 
differences based on ethnicity in abdominal adiposity and blood biochemistry. In 441 
particular, it may have provided a reason for the increased VAT in a single Polynesian 442 
athlete, which was unexpected given the high training load and results of the other 443 
athletes. Secondly, information on the medical history of the athletes and their 444 
families would have allowed exploration into possible hereditary influences. This may 445 
have provided some insight into the underlying reason one athlete displayed 446 
significantly higher VAT. Of note is that the changes this athlete made to his 447 
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abdominal adiposity over the pre-season were in line with previous research, namely 448 
that VAT (1421 g) was lost preferentially to SAT (631 g) (Verheggen et al., 2016). 449 
Finally, the research was limited by the relatively small sample size, as is inherent in 450 
all elite-level studies due to the rarity and availability of elite athletes. Given this, the 451 
findings may not be representative of an entire ethnic group within a specific sport, or 452 
within a general athletic population. However, given the strength of the findings in 453 
this study, and the health data available in general Polynesian populations, while 454 
inter-individual variability in VAT is evident, it is likely ethnicity plays a role in 455 
cardiometabolic disease risk markers in “supersized” athletes. 456 
 457 
This study identified significant differences in cardiometabolic disease risk factors 458 
based on ethnicity in elite rugby union athletes, with Polynesians having higher values 459 
for VAT and several lipid markers. Although athletes of both ethnicities had 460 
meaningful reductions to VAT as a result of pre-season training, it is possible that 461 
Polynesian athletes may be predisposed to the higher VAT and blood biochemistry 462 
markers associated with cardiometabolic disease risk. Further investigations are 463 
advocated to explore the underlying reasons for these findings, and the long-term 464 
cardiometabolic health implications in elite “supersized” Polynesian athletes.  465 
 466 
Acknowledgements 467 
 468 
See Cover Letter (to keep blinded from reviewers). 469 
 470 
Declarations of Interest 471 
 472 
 20 
All authors declare they have no conflicts of interest relevant to the context of this 473 
study. 474 
References 475 
 476 
Ackland, T. R., Lohman, T. G., Sundgot-Borgen, J., Maughan, R. J., Meyer, N. L., 477 
Stewart, A. D., & Muller, W. (2012). Current status of body composition assessment 478 
in sport: review and position statement on behalf of the ad hoc research working 479 
group on body composition health and performance, under the auspices of the I.O.C. 480 
Medical Commission. Sports Medicine, 42(3), 227-249. 481 
 482 
Alberti, K. G., Zimmet, P., & Shaw, J. (2006). Metabolic syndrome--a new world-483 
wide definition. A Consensus Statement from the International Diabetes Federation. 484 
Diabetic Medicine, 23(5), 469-480. 485 
 486 
Baim, S., Binkley, N., Bilezikian, J. P., Kendler, D. L., Hans, D. B., Lewiecki, E. M. 487 
& Silverman, S. (2008). Official Positions of the International Society for Clinical 488 
Densitometry and executive summary of the 2007 ISCD Position Development 489 
Conference. Jounral of Clinical Densitometry, 11(1), 75-91. 490 
 491 
Barry, V. W., Baruth, M., Beets, M. W., Durstine, J. L., Liu, J., & Blair, S. N. (2014).  492 
Fitness vs. fatness on all-cause mortality: a meta-analysis. Progress in Cardiovascular 493 
Diseases, 56(4), 382-390. 494 
 495 
Bilsborough, J. C., Greenway, K., Livingstone, S., Cordy, J., & Coutts, A. J. (2016). 496 
Changes in anthropometry, upper-body strength, and nutrient intake in professional 497 
 21 
Australian football players during a season. International Journal of Sports 498 
Physiology and Performance, 11, 290-300.  499 
Bindon, J. R., & Baker, P. T. (1997). Bergmann's rule and the thrifty genotype. 500 
American Journal of Physical Anthropology, 104(2), 201-210. 501 
 502 
Bosch, T., Burruss, T., Weir, N., Fielding, K., Engel, B., Weston, T., & Dengel. D. R. 503 
(2014). Abdominal body composition differences in NFL football players. Journal of 504 
Strength and Conditioning Research, 28(12), 3313-3319.  505 
 506 
Bradley, W. J., Cavanagh, B. P., Douglas, W., Donovan, T. F., Morton, J. P., & Close, 507 
G. L. (2015). Quantification of training load, energy intake, and physiological 508 
adaptations during a rugby preseason: a case study from an elite European rugby 509 
union squad. Journal of Strength and Conditioning Research, 29(2), 534-544. 510 
 511 
Demerath, E. W., Sun, S. S., Rogers, N., Lee, M., Reed, D., Choh, A. C., … Towne, 512 
B. (2007). Anatomical patterning of visceral adipose tissue: race, sex, and age 513 
variation. Obesity (Silver Spring), 15(12), 2984-2993. 514 
 515 
Despres, J. P., & Lemieux, I. (2006). Abdominal obesity and metabolic syndrome. 516 
Nature, 444(7121), 881-887. 517 
 518 
Drenowatz, C., & Eisenmann, J. C. (2011). Validation of the SenseWear Armband at 519 
high intensity exercise. European Journal of Applied Physiology, 111(5), 883-887. 520 
 521 
 522 
 22 
Fogelholm, M. (2010). Physical activity, fitness and fatness: relations to mortality, 523 
morbidity and disease risk factors. A systematic review. Obesity Reviews, 11(3), 202-524 
221. 525 
 526 
Guo, J., Zhang, X., Wang, L., Guo, Y., & Xie, M. (2013). Prevalence of metabolic 527 
syndrome and its components among Chinese professional athletes of strength sports 528 
with different body weight categories. PLoS One, 8(11), e79758. 529 
 530 
Hughes-Austin, J. M., Larsen, B. A., & Allison, M. A. (2013). Visceral adipose tissue 531 
and cardiovascular disease risk. Current Cardiovascular Risk Reports, 7, 95-101. 532 
 533 
Hume, P. A., Theadom, A., Lewis, G. N., Quarrie, K. L., Brown, S. R., Hill, R. & 534 
Marshall, S. W. (2017). A Comparison of Cognitive Function in Former Rugby Union 535 
Players Compared with Former Non-Contact-Sport Players and the Impact of 536 
Concussion History. Sports Medicine, 47(6), 1209-1220. 537 
 538 
Ismail, I., Keating, S. E., Baker, M. K., & Johnson, N. A. (2012). A systematic review 539 
and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral 540 
fat. Obesity Reviews, 13(1), 68-91. 541 
 542 
Lear, S. A., Humphries, K. H., Kohli, S., Frohlich, J. J., Birmingham, C. L., & 543 
Mancini, G. B. (2007). Visceral adipose tissue, a potential risk factor for carotid 544 
atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-545 
CHAT). Stroke, 38(9), 2422-2429. 546 
 547 
 23 
Magkos, F., & Yannakoulia, M. (2003). Methodology of dietary assessment in 548 
athletes: concepts and pitfalls. Current Opinion in Clinical Nutrition and Metabolic 549 
Care, 6(5), 539-549.  550 
 551 
Maillard, F. , Pereira, B., & Boisseau, N. (2018). Effect of high-intensity interval 552 
training on total, abdominal and visceral fat mass: A meta-analysis. Sports Medicine, 553 
48(2), 269-288. 554 
 555 
Matsuzawa, Y., Shimomura, I., Nakamura, T., Keno, Y., & Tokunaga, K. (1993). 556 
Pathophysiology and pathogenesis of visceral fat obesity. Annals of the New York 557 
Academy of Sciences, 676, 270-278.  558 
 559 
Miller, M. A., Croft, L. B., Belanger, A. R., Romero-Corral, A., Somers, V. K., 560 
Roberts, A. J., & Goldman, M. E. (2008). Prevalence of metabolic syndrome in 561 
retired National Football League players. American Journal of Cardiology, 101(9), 562 
1281-1284. 563 
 564 
Murata, H., Oshima, S., Torii, S., Taguchi, M., & Higuchi, M. (2016). Characteristics 565 
of body composition and cardiometabolic risk of Japanese male heavyweight Judo 566 
athletes. Journal of Physiological Anthropology, 35, 10. 567 
 568 
Nana, A., Slater, G. J., Stewart, A. D., & Burke, L. M. (2015). Methodology review: 569 
using dual-energy X-ray absorptiometry (DXA) for the assessment of body 570 
composition in athletes and active people. International Journal of Sports Nutrition 571 
and Exercise Metabolism, 25(2), 198-215. 572 
 24 
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., … 573 
Gakidou, E. (2014). Global, regional, and national prevalence of overweight and 574 
obesity in children and adults during 1980-2013: a systematic analysis for the Global 575 
Burden of Disease Study 2013. Lancet, 384(9945), 766-781. 576 
 577 
Norton, K., Whittingham, N., Carter, L., Kerr, D., Gore, C., & Marfell-Jones, M. 578 
(2006). Anthropometrica (K. Norton & T. Olds Eds). Marrickville: Southwood Press. 579 
 580 
Olds, T. (2001). The evolution of physique in male rugby union players in the 581 
twentieth century. Journal of Sports Sciences, 19(4), 253-262. 582 
 583 
Pickhardt, P. J., Jee, Y., O'Connor, S. D., & del Rio, A. M. (2012). Visceral adiposity 584 
and hepatic steatosis at abdominal CT: association with the metabolic syndrome. AJR: 585 
American Journal of Roentgenology, 198(5), 1100-1107. 586 
 587 
Rush, E. C., Freitas, I., & Plank, L. D. (2009). Body size, body composition and fat 588 
distribution: comparative analysis of European, Maori, Pacific Island and Asian 589 
Indian adults. British Journal of Nutrition, 102(4), 632-641. 590 
 591 
Schweitzer, L., Geisler, C., Pourhassan, M., Braun, W., Gluer, C. C., Bosy-Westphal, 592 
A., &  Muller, M. J. (2015). What is the best reference site for a single MRI slice to 593 
assess whole-body skeletal muscle and adipose tissue volumes in healthy adults? 594 
American Journal of Clinical Nutrition, 102(1), 58-65. 595 
 596 
 597 
 25 
Sedeaud, A., Marc, A., Schipman, J., Tafflet, M., Hager, J. P., & Toussaint, J. F. 598 
(2012). How they won Rugby World Cup through height, mass and collective 599 
experience. British Journal of Sports Medicine, 46(8), 580-584. 600 
 601 
Shen, W., Wang, Z., Punyanita, M., Lei, J., Sinav, A., Kral, J. G., … Heymsfield, S. 602 
B. (2003). Adipose tissue quantification by imaging methods: a proposed 603 
classification. Obesity Research, 11(1), 5-16. 604 
 605 
Swainson, M. G., Batterham, A. M., Tsakirides, C., Rutherford, Z. H., & Hind, K. 606 
(2017). Prediction of whole-body fat percentage and visceral adipose tissue mass from 607 
five anthropometric variables. PLoS One, 12, e0177175. 608 
 609 
Swinburn, B. A., Ley, S. J., Carmichael, H. E., & Plank, L. D. (1999). Body size and 610 
composition in Polynesians. International Journal of Obesity and Related Metabolic 611 
Disorders, 20(10), 1178-1183. 612 
 613 
Tchernof, A., & Despres, J. P. (2013). Pathophysiology of human visceral obesity: an 614 
update. Physiological Reviews, 93(1), 359-404. 615 
 616 
Tonkin, A., Barter, P., Best, J., Boyden, A., Furler, J., Hossack, K. … Clune, E. 617 
(2005). National Heart Foundation of Australia and the Cardiac Society of Australia 618 
and New Zealand: position statement on lipid management 2005. Heart, Lung & 619 
Circulation, 14, 275-291. 620 
 621 
 622 
 26 
Trexler, E. T., Smith-Ryan, A. E., Defreese, J. D., Marshall, S. W., Guskiewicz, K. 623 
M., & Kerr, Z. Y. (2018). Associations between BMI Change and Cardiometabolic 624 
Risk in Retired Football Players. Medicine and Science in Sports and Exercise, 50(4), 625 
684-690. 626 
 627 
Tucker, A. M., Vogel, R. A., Lincoln, A. E., Dunn, R. E., Ahrensfield, D. C., Allen, 628 
T. W., … Yates, A. P. (2009). Prevalence of cardiovascular disease risk factors 629 
among National Football League players. JAMA, 301(20), 2111-2119. 630 
 631 
Verheggen, R. J., Maessen, M. F., Green, D. J., Hermus, A. R., Hopman, M. T., & 632 
Thijssen, D. H. (2016). A systematic review and meta-analysis on the effects of 633 
exercise training versus hypocaloric diet: distinct effects on body weight and visceral 634 
adipose tissue. Obesity Reviews, 17(8), 664-690. 635 
 636 
Zemski, A. J., Hind, K., Keating, S. E., Broad, E. M., Marsh, D. J., & Slater, G. J. 637 
(2019). Same-day versus consecutive-day precision error of dual-energy X-ray 638 
absorptiometry for interpreting body composition change in resistance trained 639 
athletes. Jounral of Clinical Densitometry, 22(1), 104-114. 640 
 641 
Zemski, A. J., Keating, S. E., Broad, E. M., Marsh, D. J., & Slater, G. J. (2018). 642 
Abdominal adiposity distribution in elite rugby union athletes using magnetic 643 
resonance imaging. Sport Sciences for Health, (in press). 644 
 645 
 646 
 647 
 27 
Appendicies  648 
 649 
Appendix 1: Three-dimensional images of subcutaneous adipose tissue (SAT; green) 650 
and visceral adipose tissue (VAT; red). a) Low VAT (left) vs high VAT (right). b) 651 
Caucasian (left; ~21% body fat, ~4700 cm3 SAT, ~ 600 cm3 VAT) vs Polynesian 652 
(right; 19% body fat, 5900 cm3 SAT, 800 cm3 VAT). c) Changes in SAT and VAT in 653 
the same athlete over the pre-season. 654 
655 
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 656 
Table 1: Descriptive statistics of athletes grouped according to ethnicity. 
 Caucasians 
(n=11) 
Polynesians 
(n=11) 
  
 Start  
Pre-Season 
End  
Pre-Season 
Start  
Pre-Season 
End  
Pre-Season 
T-Test 
p-value 
ANCOVA  
p-value 
Age (years) 22.1 ± 2.4 - 23.5 ± 3.8 - 0.322 - 
Surface Anthropometry       
   Stature (cm) 189.4 ± 8.7 - 184.1 ± 7.6 - 0.140 - 
   Body Mass (kg) 101.2 ± 14.2 101.7 ± 14.0 101.8 ± 13.9 100.8 ± 13.6 0.926 0.053 
   Sum of 7 SF (mm)# 66.8 (56.4 to 90.2) 54.7 (47.4 to 71.8) 78.6 (67.1 to 103.7) 65.6 (55.5 to 86.7) 0.150 0.708 
   WC (cm) 88.7 ± 5.0 87.9 ± 4.5 91.3 ± 6.2 88.5 ± 5.9 0.292 0.007^ 
   BMI (kg/m2) 28.1 ± 2.1 28.2 ± 2.0 29.9 ± 2.6 29.7 ± 2.7 0.081 0.098 
   WHt (cm/m2) 0.47 ± 0.02 0.46 ± 0.02 0.50 ± 0.03 0.48 ± 0.03 0.019* 0.015^ 
DXA          
   Whole body LM (g) 84005 ± 10306 86430 ± 10447 82680 ± 10173 83795 ± 10431 0.767 0.658 
   Whole body FM (g) 15495 ± 4839 13338 ± 4353 17572 ± 4214 15278 ± 3897 0.296 0.809 
   Whole body FM (%) 14.7 ± 3.0 12.7 ± 2.7 16.7 ± 2.3 14.7 ± 2.4 0.099 0.515 
   Android FM (g) 1005 ± 416 818 ± 375 1396 ± 570 1083 ± 462 0.078 0.304 
   Android FM (%) 14.5 ± 3.8  12.0 ± 3.7 19.4 ± 5.0 15.5 ± 4.5 0.020* 0.351 
 29 
   Gynoid FM (g) 3249 ± 1260 2788 ± 1167 3615 ± 779 3145 ± 786 0.423 0.849 
   Gynoid FM (%) 17.6 ± 4.2 15.2 ± 4.0 20.2 ± 3.0 17.9 ± 3.2 0.116 0.694 
   FMI (kg/m2) 4.3 ± 1.2 3.7 ± 1.1 5.1 ± 1.0 4.5 ± 1.0 0.077 0.915 
MRI       
   SAT Volume (cm3) 2279 ± 1014 1888 ± 979 3424 ± 1529 2886 ± 1370 0.068 0.786 
   VAT Volume (cm3)# 373 (239 to 649) 206 (181 to 420) 662 (434 to 799) 400 (213 to 547) 0.043* 0.534 
Blood Biochemistry       
   Fasting Insulin (mU/L) 7.6 ± 4.5 11.0 ± 4.8 7.2 ± 5.3 9.4 ± 4.8 0.717 0.457 
   Fasting Glucose (mmol/L) 4.2 ± 0.3 4.2 ± 0.7 4.1 ± 0.4 4.3 ± 0.2 0.848 0.452 
   Total Cholesterol (mmol/L)# 4.3 (3.6 to 4.9) 4.2 (2.8 to 4.7) 4.9 (4.3 to 5.5) 5.0 (4.8 to 5.2) 0.057 0.029^ 
   Triglycerides (mmol/L)# 0.6 (0.3 to 0.7) 0.8 (0.6 to 0.9) 0.8 (0.6 to 1.0) 1.0 (0.8 to 1.2) 0.050* 0.151 
   HDL-C (mmol/L) 1.4 ± 0.2 1.4 ± 0.2 1.3 ± 0.2 1.3 ± 0.2 0.096 0.936 
   LDL-C (mmol/L)# 2.2 (1.8 to 2.4) 2.2 (1.8 to 2.5) 2.9 (2.5 to 3.7) 3.1 (2.9 to 3.4) 0.019* 0.122 
DXA = dual-energy X-ray absorptiometry; MRI = magnetic resonance imaging; SF = skinfolds; WC = waist circumference; BMI = body mass index; WHt = waist to 
height ratio; FM = fat mass; LM = lean mass; FMI = fat mass index; SAT = subcutaneous adipose tissue; VAT = visceral adipose tissue; HDL-C = high-density 
lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol 
Data presented as mean ± standard deviation 
# Log transformed, data presented as median (IQR) 
Independent T-test – * Significantly different at baseline (p ≤ 0.05) 
 30 
ANCOVA – ^ Significant interaction between ethnicity and change over pre-season (p ≤ 0.05) 
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Table 2: Correlations between adiposity measures and blood biochemical markers of 
cardiometabolic disease risk with magnetic resonance imaging measured SAT and VAT. 
 Baseline Change Over Pre-Season 
 MRI SAT  
r# 
MRI VAT  
r# 
MRI SAT  
r 
MRI VAT  
r# 
Mass (kg) 0.752** 0.365 0.484* 0.299 
Sum 7 Skinfolds (mm) 0.866** 0.639** 0.689** 0.575** 
Waist Circumference (cm) 0.842** 0.494* 0.558** 0.578** 
BMI (kg/m2) 0.820** 0.427* 0.496* 0.329 
WHt (cm/m2) 0.525* 0.427* 0.548** 0.588** 
Total Fat Mass (kg) 0.953** 0.709** 0.557** 0.496* 
Total Fat Mass (%) 0.901** 0.723** 0.473* 0.453* 
Android Fat Mass (kg) 0.964** 0.785** 0.625** 0.462* 
Android Fat Mass (%) 0.897** 0.834** 0.587** 0.377 
Gynoid Fat Mass (kg) 0.881** 0.581** 0.488* 0.491* 
Gynoid Fat Mass (%) 0.737** 0.540** 0.420 0.506* 
FMI (Fat Mass / Ht (m)2) 0.939** 0.680** 0.545** 0.500* 
 31 
Fasting Insulin (mU/L) 0.386 0.263 0.309 0.070 
Fasting Glucose (mmol/L) 0.104 0.372 0.272 0.096 
Total Cholesterol (mmol/L) 0.435* 0.564** -0.010 0.302 
Triglycerides (mmol/L) 0.705** 0.709** 0.087 0.107 
HDL-C (mmol/L) 0.098 -0.044 0.148 -0.067 
LDL-C (mmol/L) 0.225 0.411 -0.104 0.078 
BMI = body mass index; WHt = waist to height ratio; FMI = fat mass index; HDL-C = high-density 
lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; MRI = magnetic resonance 
imaging; SAT = subcutaneous adipose tissue; VAT = visceral adipose tissue; 
** p ≤ 0.01, * p ≤ 0.05 
r = Pearson’s correlation coefficient; r# = Spearman’s correlation coefficient 
r < 0.1; small, 0.1 ≤ r < 0.3; moderate, 0.3 ≤ r < 0.5; large, 0.5 ≤ r < 0.7; very large, 0.7 ≤ r < 0.9; almost 
perfect, 0.9 ≤ r < 1.0; and perfect, r = 1.0. 
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 665 
Table 3: Individual athletes who made meaningful reductions in whole body and regional body 
composition (> LSC 95%CI – technical error and biological variation) during the pre-season. 
 
All 
(n=22) 
Ethnicity 
(n=22) 
Caucasians 
(n=11) 
Polynesians 
(n=11) 
DXA 
Total Fat Mass (g) 17 (77%) 9 (82%) 8 (73%) 
Total Fat Mass (%) 17 (77%) 9 (82%) 8 (73%) 
Android Fat Mass (g) 20 (91%) 10 (91%) 10 (91%) 
Android Fat Mass (%) 19 (86%) 9 (82%) 10 (91%) 
Gynoid Fat Mass (g) 15 (68%) 7 (64%) 8 (73%) 
Gynoid Fat Mass (%) 5 (23%) 2 (18%) 3 (27%) 
Surface 
Anthropometry 
Sum of 7 Skinfolds (mm)a 21 (95%) 11 (100%) 10 (91%) 
Waist Circumference (cm)b 15 (68%) 5 (45%) 10 (91%) 
MRI 
SAT Volume (cm3) 19 (86%) 10 (91%) 9 (82%) 
VAT Volume (cm3)c 21 (95%) 11 (100%) 10 (91%) 
Data shown are – number of athletes (% of athletes) 
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 680 
 681 
DXA = dual-energy X-ray absorptiometry; MRI = magnetic resonance imaging 
a 1 athlete increased sum of 7 skinfolds (1 Polynesian) 
b 3 athletes increased waist circumference (2 Caucasian, 1 Polynesian) 
c 1 athlete increased VAT (1 Polynesian) 
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Figure 1: Pre-season changes in abdominal visceral (VAT) and subcutaneous (SAT) 682 
adiposity. Open circles represent Caucasians, closed circles represent Polynesians. Circles 683 
joined by lines represent each individual athlete’s SAT and VAT values at the start and end 684 
of pre-season. 685 
